Amgen (AMGN) Cash from Financing Activities (2009 - 2026)
Amgen's quarterly Cash from Financing Activities came in at $1.4 billion in Q1 2026, up 134.96% year-on-year from $611.2 million in Q1 2025, and up 217.13% quarter-over-quarter from -$1.2 billion in Q4 2025.
Amgen has reported Cash from Financing Activities for 18 years, with the latest figure at $1.4 billion in Q1 2026.
- For the quarter ending Q1 2026, Cash from Financing Activities rose 134.96% year-over-year to $1.4 billion; the trailing twelve-month figure through Mar 2026 stood at -$5.3 billion (up 55.0% YoY), and the FY2025 full-year result was -$10.9 billion, down 15.34% from the prior year.
- Cash from Financing Activities for Q1 2026 stood at $1.4 billion, up from -$1.2 billion in the prior quarter.
- The five-year high for Cash from Financing Activities was $21.5 billion in Q1 2023, with the low at -$4.1 billion in Q1 2025.
- Average Cash from Financing Activities over 5 years is -$107.5 million, with a median of -$1.4 billion recorded in 2024.
- Peak annual rise in Cash from Financing Activities reached 712.09% in 2023, while the deepest fall reached 226.26% in 2023.
- Tracing AMGN's Cash from Financing Activities over 5 years: stood at -$1.0 billion in 2022, then surged by 362.54% to $2.8 billion in 2023, then slumped by 151.09% to -$1.4 billion in 2024, then increased by 12.86% to -$1.2 billion in 2025, then soared by 217.13% to $1.4 billion in 2026.
- The last three Cash from Financing Activities figures came in at $1.4 billion (Q1 2026), -$1.2 billion (Q4 2025), and -$2.9 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | -3.47 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 530.00 Mn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 919.00 Mn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | -2.98 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 1.44 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | -4.24 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | -2.86 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | -1.56 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.44 Bn |
| Mar 31, 2026 | 1.44 Bn |
| Dec 31, 2025 | -1.23 Bn |
| Dec 31, 2025 | -1.23 Bn |
| Sep 30, 2025 | -2.85 Bn |
| Sep 30, 2025 | -2.85 Bn |
| Jun 30, 2025 | -2.67 Bn |
| Jun 30, 2025 | -2.67 Bn |
| Mar 31, 2025 | -4.11 Bn |
| Mar 31, 2025 | -4.11 Bn |
| Dec 31, 2024 | -1.41 Bn |
| Dec 31, 2024 | -1.41 Bn |
| Sep 30, 2024 | -3.65 Bn |
| Sep 30, 2024 | -3.65 Bn |
| Jun 30, 2024 | -2.65 Bn |
| Jun 30, 2024 | -2.65 Bn |
| Mar 31, 2024 | -1.71 Bn |
| Mar 31, 2024 | -1.71 Bn |
| Dec 31, 2023 | 2.75 Bn |
| Dec 31, 2023 | 2.75 Bn |
| Sep 30, 2023 | -2.01 Bn |
| Sep 30, 2023 | -2.01 Bn |
| Jun 30, 2023 | -1.21 Bn |
| Jun 30, 2023 | -1.21 Bn |
| Mar 31, 2023 | 21.51 Bn |
| Mar 31, 2023 | 21.51 Bn |
| Dec 31, 2022 | -1.05 Bn |
| Dec 31, 2022 | -1.05 Bn |
| Sep 30, 2022 | 1.59 Bn |
| Sep 30, 2022 | 1.59 Bn |
| Jun 30, 2022 | -1.06 Bn |
| Jun 30, 2022 | -1.06 Bn |
| Mar 31, 2022 | -3.51 Bn |
| Mar 31, 2022 | -3.51 Bn |
| Dec 31, 2021 | -6.56 Bn |
| Dec 31, 2021 | -6.56 Bn |
| Sep 30, 2021 | 2.85 Bn |
| Sep 30, 2021 | 2.85 Bn |
| Jun 30, 2021 | -2.62 Bn |
| Jun 30, 2021 | -2.62 Bn |
| Mar 31, 2021 | -1.94 Bn |
| Mar 31, 2021 | -1.94 Bn |
| Dec 31, 2020 | -3.59 Bn |
| Dec 31, 2020 | -3.59 Bn |
| Sep 30, 2020 | -1.80 Bn |
| Sep 30, 2020 | -1.80 Bn |
| Jun 30, 2020 | 775.00 Mn |
| Jun 30, 2020 | 775.00 Mn |
| Mar 31, 2020 | -254.00 Mn |
| Mar 31, 2020 | -254.00 Mn |
| Dec 31, 2019 | -1.93 Bn |
| Dec 31, 2019 | -1.93 Bn |
| Sep 30, 2019 | -2.86 Bn |
| Sep 30, 2019 | -2.86 Bn |
| Jun 30, 2019 | -5.99 Bn |
| Jun 30, 2019 | -5.99 Bn |
| Mar 31, 2019 | -4.99 Bn |
| Mar 31, 2019 | -4.99 Bn |
| Dec 31, 2018 | -3.57 Bn |
| Dec 31, 2018 | -3.57 Bn |
| Sep 30, 2018 | -2.58 Bn |
| Sep 30, 2018 | -2.58 Bn |
| Jun 30, 2018 | -4.65 Bn |
| Jun 30, 2018 | -4.65 Bn |
| Mar 31, 2018 | -11.69 Bn |
| Mar 31, 2018 | -11.69 Bn |
| Dec 31, 2017 | -2.13 Bn |
| Dec 31, 2017 | -2.13 Bn |
| Sep 30, 2017 | -1.11 Bn |
| Sep 30, 2017 | -1.11 Bn |
| Jun 30, 2017 | -1.24 Bn |
| Jun 30, 2017 | -1.24 Bn |
| Mar 31, 2017 | -2.11 Bn |
| Mar 31, 2017 | -2.11 Bn |
| Dec 31, 2016 | -2.12 Bn |
| Dec 31, 2016 | -2.12 Bn |
| Sep 30, 2016 | 582.00 Mn |
| Sep 30, 2016 | 582.00 Mn |
| Jun 30, 2016 | -2.29 Bn |
| Jun 30, 2016 | -2.29 Bn |
| Mar 31, 2016 | 1.23 Bn |
| Mar 31, 2016 | 1.23 Bn |
| Dec 31, 2015 | -922.00 Mn |
| Dec 31, 2015 | -922.00 Mn |
| Sep 30, 2015 | -1.46 Bn |
| Sep 30, 2015 | -1.46 Bn |
| Jun 30, 2015 | 6.00 Mn |
| Jun 30, 2015 | 6.00 Mn |
| Mar 31, 2015 | -1.40 Bn |
| Mar 31, 2015 | -1.40 Bn |
| Dec 31, 2014 | -3.16 Bn |
| Dec 31, 2014 | -3.16 Bn |
| Sep 30, 2014 | -513.00 Mn |
| Sep 30, 2014 | -513.00 Mn |
| Jun 30, 2014 | 896.00 Mn |
| Jun 30, 2014 | 896.00 Mn |
| Mar 31, 2014 | -495.00 Mn |
| Mar 31, 2014 | -495.00 Mn |
| Dec 31, 2013 | 3.81 Bn |
| Dec 31, 2013 | 3.81 Bn |
| Sep 30, 2013 | 2.79 Bn |
| Sep 30, 2013 | 2.79 Bn |
| Jun 30, 2013 | -283.00 Mn |
| Jun 30, 2013 | -283.00 Mn |
| Mar 31, 2013 | -3.59 Bn |
| Mar 31, 2013 | -3.59 Bn |
| Dec 31, 2012 | -1.35 Bn |
| Dec 31, 2012 | -1.35 Bn |
| Sep 30, 2012 | 1.42 Bn |
| Sep 30, 2012 | 1.42 Bn |
| Jun 30, 2012 | 1.71 Bn |
| Jun 30, 2012 | 1.71 Bn |
| Mar 31, 2012 | -1.37 Bn |
| Mar 31, 2012 | -1.37 Bn |
| Dec 31, 2011 | 1.69 Bn |
| Dec 31, 2011 | 1.69 Bn |
| Sep 30, 2011 | -2.22 Bn |
| Sep 30, 2011 | -2.22 Bn |
| Jun 30, 2011 | 2.35 Bn |
| Jun 30, 2011 | 2.35 Bn |
| Mar 31, 2011 | -2.50 Bn |
| Mar 31, 2011 | -2.50 Bn |
| Dec 31, 2010 | -1.18 Bn |
| Dec 31, 2010 | -1.18 Bn |
| Sep 30, 2010 | 1.21 Bn |
| Sep 30, 2010 | 1.21 Bn |
| Jun 30, 2010 | -683.00 Mn |
| Jun 30, 2010 | -683.00 Mn |
| Mar 31, 2010 | -576.00 Mn |
| Mar 31, 2010 | -576.00 Mn |
| Dec 31, 2009 | -2.18 Bn |
| Dec 31, 2009 | -2.18 Bn |
| Sep 30, 2009 | 55.00 Mn |
| Sep 30, 2009 | 55.00 Mn |
| Jun 30, 2009 | 93.00 Mn |
| Jun 30, 2009 | 93.00 Mn |
| Mar 31, 2009 | 5.00 Mn |
| Mar 31, 2009 | 5.00 Mn |